| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a724c9f43b5b2e7663f1da0c511e8c16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6fdcf48483be336046a164f5bf4c1cf |
| publicationDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10407441-B2 |
| titleOfInvention |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| abstract |
The invention features compositions and methods for treating or preventing a neoplasia. More specifically, the invention provides compositions and methods for disrupting the interaction of a BET family polypeptide comprising a bromodomain with chromatin (e.g., disrupting a bromodomain interaction with an acetyl-lysine modification present on a histone N-terminal tail). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11306105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10676484-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406645-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10925881-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881668-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10913752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793571-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10730860-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446309-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019046541-A1 |
| priorityDate |
2010-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |